52-Week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-Positive Chronic Hepatitis B

Background and Aims: The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. The efficacy and safety of this approach applied to telbivudine treatment has not been investigated. Methods: A mul...

Full description

Bibliographic Details
Main Author: Piratvisuth, Teerha (author)
Other Authors: Komolmit, Piyawat (author), Tanwandee, Tawesak (author), Sukeepaisarnjaroen, Wattana (author), Chan, Henry (author), Pessôa, Mário Guimarães (author), Fassio, Eduardo (author), Ono, Suzane Kioko (author), Bessone, Fernando (author), Daruich, Jorge (author), Zeuzem, Stefan (author), Cheinquer, Hugo (author), Pathan, Rashidkhan (author), Dong, Yuhong (author), Trylesinski, Aldo (author)
Format: other article
Language:eng
Published: 2019
Subjects:
Antígenos E da Hepatite B
Hepatite B crônica
Online Access:http://hdl.handle.net/10183/200470
Country:Brazil
Oai:oai:www.lume.ufrgs.br:10183/200470

Internet

http://hdl.handle.net/10183/200470

Similar Items